loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 20067 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 NAPROXEN (2)

filter

01 ATNAHS PHARMA US (2)

filter

01 TABLET, DELAYED RELEASE;ORAL (2)

filter

01 375MG (1)

02 500MG (1)

filter

01 USA (2)

URL Supplier Web Content
TABLET, DELAYED RELEAS...
375MG
EC-NAPROSYN
USA
20067
1994-10-14
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET, DELAYED RELEAS...
500MG
EC-NAPROSYN
USA
20067
1994-10-14
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 20067

Looking for CTD TGA MCC DOSSIER APPLICATION 20067 2

19

ATNAHS PHARMA UK LIMITED, based in United Kingdom, is a pharmaceutical company.

One of their notable products is NAPROXEN, with a corresponding application number 20067 and regulatory information .

proudly manufactured in the

approval since 1994-10-14

ATNAHS PHARMA UK LIMITED's EC-NAPROSYN TABLET, DELAYED RELEASE;ORAL, medication with 375MG of NAPROXEN.

18

ATNAHS PHARMA UK LIMITED, based in United Kingdom, is a pharmaceutical company.

One of their notable products is NAPROXEN, with a corresponding application number 20067 and regulatory information .

proudly manufactured in the

approval since 1994-10-14

ATNAHS PHARMA UK LIMITED's EC-NAPROSYN TABLET, DELAYED RELEASE;ORAL, medication with 500MG of NAPROXEN.

Post Enquiry
POST ENQUIRY